ERD

QUANTEXBIO | Quantitative and Experimental Biology

01-11-2015

-

31-10-2020

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

CohesiNet | Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases

01-01-2023

-

31-12-2026

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

aDDRess | Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response

01-03-2019

-

31-12-2023

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

PERSIST-SEQ | Building a reproducible single-cell experimental workflow to capture tumour drug persistence

01-07-2021

-

30-06-2026

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

BtRAIN | Brain barriers training

01-09-2015

-

31-08-2019

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

COSMIC | COmbatting disorders of adaptive immunity with Systems MedICine

01-01-2018

-

30-09-2022

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network

01-09-2016

-

30-11-2020

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

Sagittarius | A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL

01-07-2023

-

30-06-2028

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

NANOFACTURING | The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals

01-02-2015

-

31-01-2019

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

SHAPINCELLFATE | Impact of cell shapes on cell behaviour and fate

01-04-2023

-

31-03-2029

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

OrganVision | OrganVision: Technology for real-time visualizing and modelling of fundamental process in living organoids towards new insights into organ-specific health, disease, and recovery

01-07-2021

-

30-06-2025

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

TARGET | Targeting DNA repair pathways, sparking anti cancer immunity

01-10-2021

-

30-09-2026

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

METABALANCANCER | Setting the optimal balance between metabolite supplementation and deprivation in cancer therapy

01-12-2023

-

30-11-2028

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

BCRlossToBWinner | Genetic determinants promoting resistance to BCR-loss in B-cell lymphomas

01-12-2020

-

25-11-2023

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

DDRNA | DDRNA-based cancer therapy targeted telomeres

01-06-2015

-

30-11-2016

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

RNAging | The role of non coding RNA in organismal ageing

01-03-2017

-

31-08-2018

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

FIREQUENCHER | Pharmacological inhibition of macrophage activation

01-01-2021

-

30-06-2022

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

TELOVACCINE | Targeting telomeric DNA damage response as a new strategy to fight immunosenescence and improve vaccine response

01-09-2023

-

28-02-2025

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

FolLyway2HIT | Deciphering the role of immunoglobulin classes in shaping Follicular Lymphoma molecular heterogeneity and evolution

01-09-2023

-

31-08-2025

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

REPSUMODDT | Mechanisms and regulators coordinating replication integrity and DNA damage tolerance.

01-07-2016

-

31-12-2021

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

V-EPC | Inherited disfunctions of brain microcirculation

01-09-2017

-

31-08-2022

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

TeloRNAging | The role of damage-induced non coding RNA in the control of DNA damage response activation at telomeres in aging

01-10-2019

-

30-09-2024

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

ENVERESP | Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity

01-04-2016

-

31-03-2018

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

METAREPAIR | INVESTIGATING THE IMPACT OF NUTRITIONAL METABOLISM ON DNA DAMAGE REPAIR IN CANCER

01-07-2021

-

30-06-2023

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

SPLICANCER | Regulation and reprogramming of alternative splicing in cellular transformation

01-07-2017

-

30-06-2019

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

MECHANOCHECK | ATR-mediated mechanotransduction and connections with the actin cytoskeleton

01-04-2016

-

31-03-2018

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

MechanoSpectrin | Dynamic and Mechanical Role of Spectrin in Membrane-Cytoskeleton Interplay

01-06-2018

-

31-05-2020

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

EpiMetaPDO | Dissecting mechanisms of epigenetic reprogramming driving metastatic transition using cancer patient-derived organoids

01-06-2025

-

31-05-2027

Show more information

Organisation IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

Projects overview

Selected filters:

QUANTEXBIO | Quantitative and Experimental Biology

CohesiNet | Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases

aDDRess | Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response

PERSIST-SEQ | Building a reproducible single-cell experimental workflow to capture tumour drug persistence

BtRAIN | Brain barriers training

COSMIC | COmbatting disorders of adaptive immunity with Systems MedICine

SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network

Sagittarius | A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL

NANOFACTURING | The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals

SHAPINCELLFATE | Impact of cell shapes on cell behaviour and fate

OrganVision | OrganVision: Technology for real-time visualizing and modelling of fundamental process in living organoids towards new insights into organ-specific health, disease, and recovery

TARGET | Targeting DNA repair pathways, sparking anti cancer immunity

METABALANCANCER | Setting the optimal balance between metabolite supplementation and deprivation in cancer therapy

BCRlossToBWinner | Genetic determinants promoting resistance to BCR-loss in B-cell lymphomas

DDRNA | DDRNA-based cancer therapy targeted telomeres

RNAging | The role of non coding RNA in organismal ageing

FIREQUENCHER | Pharmacological inhibition of macrophage activation

TELOVACCINE | Targeting telomeric DNA damage response as a new strategy to fight immunosenescence and improve vaccine response

FolLyway2HIT | Deciphering the role of immunoglobulin classes in shaping Follicular Lymphoma molecular heterogeneity and evolution

REPSUMODDT | Mechanisms and regulators coordinating replication integrity and DNA damage tolerance.

V-EPC | Inherited disfunctions of brain microcirculation

TeloRNAging | The role of damage-induced non coding RNA in the control of DNA damage response activation at telomeres in aging

ENVERESP | Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity

METAREPAIR | INVESTIGATING THE IMPACT OF NUTRITIONAL METABOLISM ON DNA DAMAGE REPAIR IN CANCER

SPLICANCER | Regulation and reprogramming of alternative splicing in cellular transformation

MECHANOCHECK | ATR-mediated mechanotransduction and connections with the actin cytoskeleton

MechanoSpectrin | Dynamic and Mechanical Role of Spectrin in Membrane-Cytoskeleton Interplay

EpiMetaPDO | Dissecting mechanisms of epigenetic reprogramming driving metastatic transition using cancer patient-derived organoids